Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Special Topics
September 2005

Percutaneous Ethanol Sclerotherapy for Vascular Malformations in the Head and Neck

Author Affiliations

Author Affiliations: Department of Radiology, Medical University of South Carolina, Charleston.

Correspondence: John P. Deveikis, MD, Department of Radiology, Medical University of South Carolina, 169 Ashley Ave, PO Box 250322, Charleston, SC 29425 (


Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005

Arch Facial Plast Surg. 2005;7(5):322-325. doi:10.1001/archfaci.7.5.322

Vascular malformations are frequent in the head and neck. In addition to the occasional devastating cosmetic effects of large vascular malformations, some may cause significant functional impairment by encroaching on the eye, tongue, or throat. Large lesions may produce a breakdown of skin or mucosa, with resultant leakage of blood or fluid and possible infection in the lesions and surrounding tissues. Arteriovenous malformations, in particular, may develop massive bleeding spontaneously or with minor trauma. Numerous treatment options are available for treatment of these lesions. Surgical excision is the traditional treatment for vascular malformations in the head and neck. However, some lesions may be difficult to remove when they permeate and envelop normal structures, such as the facial nerve, and a less invasive mode of therapy may prevent damage to these normal structures. Percutaneous sclerotherapy was developed as a minimally invasive treatment modality for these lesions. It has also proved helpful as a preoperative adjunctive treatment of these lesions to reduce surgical blood loss and to delineate the surgical extent of resection.